Holen Sie sich die Stockscreener-App
1.68
6.67%
-0.12
Pyxis Oncology Inc Aktie (PYXS) Neueste Nachrichten
Form 4 Pyxis Oncology Inc For: 10 October By Investing.com - Investing.com South Africa
Form 4 Pyxis Oncology Inc For: 10 October By Investing.com - Investing.com Nigeria
Form 4 Pyxis Oncology Inc For: 10 October By Investing.com - Investing.com UK
Warrants for 4.9 million shares are included in a passive stake in Pyxis Oncology (PYXS). - Stock Titan
Warrants bought at Pyxis Oncology (PYXS) cannot be exercised yet, and their count is corrected. - Stock Titan
Pyxis Oncology stock fell 9.82 percent on October 6 after financing - AD HOC NEWS
A passive holder reports over 5% of Pyxis Oncology (PYXS), with some warrants excluded. - stocktitan.net
Form 4 Pyxis Oncology Inc For: 2 October By Investing.com - Investing.com Nigeria
Form 4 Pyxis Oncology Inc For: 2 October By Investing.com - Investing.com Canada
GordonMD Discloses 17.5% Stake in Pyxis Oncology Including Warrants - Kalkine Media
A 10% owner buys $2.90 share-and-warrant packages in Pyxis Oncology (PYXS). - Stock Titan
An ownership cap restricts warrant exercise for a Pyxis Oncology (PYXS) investor. - Stock Titan
Pyxis Oncology Closes $110 Million Public Offering to Advance MICVO Clinical Development - Quiver Quantitative
Pyxis Oncology Announces Closing of Up to $282.6 Million Public Offering - GlobeNewswire
Pyxis Oncology Raises $102.8 Million Net in Underwritten Equity Offering Led by Leerink, Guggenheim, Wells Fargo - TradingView
Form 424B5 Pyxis Oncology Inc For: 1 October By Investing.com - Investing.com Canada
Latham Advises on Pyxis Oncology’s Up to US$282.6 Million Public Offering - Legal Desire
Pyxis Oncology Prices Public Offering of Common Stock, Warrants - marketscreener.com
Pyxis Oncology prices $110 million public offering - Investing.com
Pyxis Oncology prices $110 million public offering By Investing.com - Investing.com Canada
Pyxis Oncology launches public offering to fund MICVO Phase 3 development - scanx.trade
Pyxis Oncology stock falls on public offering announcement - Yahoo Finance UK
Pyxis Oncology stock falls on public offering announcement - Yahoo Finance
Pyxis Oncology launches public offering of stock and warrants By Investing.com - Investing.com Canada
Pyxis Oncology Announces Proposed Registered Public Offering of Common Stock, Pre-Funded Warrants and Common Warrants - Quiver Quantitative
Pyxis Oncology (Nasdaq:PYXS)Stock Analysis - Simply Wall Street
Pyxis Oncology Inc (NASDAQ: PYXS) Share Price, PYXS Stock News, PYXS Share Price & Updates - Kalkine
Pyxis Oncology: Setbacks Costing Nearly 2 Years Of Recovery (NASDAQ:PYXS) - Seeking Alpha
Wells Fargo raises Pyxis Oncology stock price target on MICVO data By Investing.com - Investing.com South Africa
Wedbush raises Pyxis Oncology stock price target on trial data By Investing.com - Investing.com South Africa
Wedbush raises Pyxis Oncology stock price target on trial data By Investing.com - Investing.com Nigeria
Wells Fargo raises Pyxis Oncology stock price target on MICVO data By Investing.com - Investing.com Australia
Enterprise value to revenue forward of Pyxis Oncology, Inc. – NASDAQ:PYXS - TradingView
Pyxis Oncology stock price target raised to $8 by H.C. Wainwright By Investing.com - Investing.com Australia
Pyxis Oncology Stock Soars Over 5% Overnight: Here's What You Need to Know - webull.com
Pyxis Oncology (NASDAQ: PYXS) to Launch Phase 3 Trial for MICVO in Mid-2027 Following Promising Phase 1 Results - Kalkine Media
Pyxis Oncology stock price target raised to $8 by H.C. Wainwright - Investing.com Nigeria
A Quick Look at Today's Ratings for Pyxis Oncology(PYXS.US), With a Forecast Between $6 to $19 - Moomoo
Pyxis Oncology stock price target raised to $8 by H.C. Wainwright - Investing.com Australia
Wells Fargo raises Pyxis Oncology stock price target on MICVO data - Investing.com Australia
Pyxis Oncology stock price target raised to $8 by H.C. Wainwright - investing.com
Wells Fargo raises Pyxis Oncology stock price target on MICVO data - Investing.com Nigeria
Pyxis Oncology stock price target raised to $8 by H.C. Wainwright - Investing.com Canada
Wedbush raises Pyxis Oncology stock price target on trial data By Investing.com - Investing.com Australia
Wells Fargo raises Pyxis Oncology stock price target on MICVO data - Investing.com Canada
Wells Fargo raises Pyxis Oncology stock price target on MICVO data - Investing.com UK
Wells Fargo raises Pyxis Oncology stock price target on MICVO data - Investing.com
Pyxis Oncology, Inc. (PYXS) Discusses MICVO Monotherapy Phase I Clinical Data in Head and Neck Squamous Cell CarcinomaSlideshow (NASDAQ:PYXS) 2026-09-10 - Seeking Alpha
Wedbush raises Pyxis Oncology stock price target on trial data - investing.com
Wedbush raises Pyxis Oncology stock price target on trial data - Investing.com
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):